Clinical Trial Update: ESAN II - Energy Sensing in Depression [NA]

View source ↗

Summary

ESAN II is an ongoing clinical trial studying energy sensing in depression and is currently recruiting; depression and obesity are among the listed conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Obesity

Snippet

Sponsor: Medical University of Graz | Conditions: Immune System Tolerance, Depression | NA | Status: RECRUITING